Question 1

What do antiplatelet drugs do?

Accepted Answer

Antiplatelet agents reduce the ability of platelets to clump together and form blood clots. They are used to prevent heart attacks and strokes in patients with cardiovascular disease, after coronary stent placement, and after a transient ischemic attack (TIA). Clopidogrel (Plavix) is one of the most widely prescribed antiplatelets and is often combined with aspirin (dual antiplatelet therapy) in high-risk patients.

Question 2

How does clopidogrel prevent blood clots?

Accepted Answer

Clopidogrel is a prodrug that is converted by liver enzymes (primarily CYP2C19) to an active metabolite that irreversibly blocks P2Y12 ADP receptors on platelet surfaces. This prevents ADP-mediated platelet activation and aggregation. Because the block is irreversible, platelet function does not recover until new platelets are produced — which takes approximately 7–10 days after stopping the drug, an important consideration before surgery.

Question 3

What are the main risks of antiplatelet therapy?

Accepted Answer

The primary risk is bleeding — including GI bleeding, intracranial hemorrhage, and prolonged bleeding from cuts. Dual antiplatelet therapy (clopidogrel plus aspirin) carries a higher bleeding risk than either drug alone. Patients should carry identification indicating they are on antiplatelet therapy, and should inform all healthcare providers before any invasive procedure or surgery. NSAIDs and SSRIs increase bleeding risk when taken with antiplatelets.

Question 4

Is clopidogrel effectiveness affected by genetics?

Accepted Answer

Yes — clopidogrel requires CYP2C19 enzymes to convert it to its active form. Approximately 30% of people carry loss-of-function CYP2C19 variants, reducing clopidogrel's effectiveness ("clopidogrel resistance"), which may increase the risk of heart attack in patients with coronary stents. The FDA added a black-box warning about this. Genetic testing can identify poor metabolizers, and alternative agents like prasugrel or ticagrelor may be preferred for these patients. Consult your healthcare provider about whether testing is appropriate for you.

Antiplatelet Agents

Overview

How do antiplatelet agents work?

Drugs in this class

Frequently asked questions